To understand the potential mechanism that Tamarixetin inhibits CRC via DPP7 suppression, we performed GSEA analysis in the TCGA database and identified that DPP7 is closely associated with the activation of the WNT signalling pathway in CRC tumours (Figure 6A). This evidence concerns the gene DPP7 and neoplasm.